Decreased levels and functional disturbance of HDL, which are caused by low levels of apoprotein (Apo) A-I, ApoA-II, and lecithin-cholesterol acyltransferase (LCAT) (12, 13), are other lipid abnormalities commonly observed in patients with CKD. Here, LCAT is linked to chronic kidney disease.